The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

FTC sues top PBMs for inflating insulin prices, accusing them of rigging competition and hurting patients. Legal action also includes GPOs.

The four largest pharmacy benefit managers in the U.S. control 70% of the national market, and most regional PBM markets are highly concentrated, according to new data from the American Medical ...

"The call for increased regulatory oversight of PBM business practices is overwhelmingly welcomed by physicians as a check against possible anticompetitive harm resulting from low competition and high ...

Satisfaction with brick-and-mortar pharmacies dropped 10 points in 2024 alone ... loss on popular drugs like Ozempic. PBMs can do this because the three largest—CVS Caremark, Express Scripts, ...

The six largest PBMs control 95% of the prescription ... And, as the Federal Trade Commission pointed out in its report on PBMs, nearly three of every 10 Americans are reporting that they are ...

The nation’s three largest PBMs — CVS Caremark, OptumRX and Express Scripts — are owned by much larger corporations that each also own a top-10 health insurer. The Federal Trade Commission ...

Satisfaction with brick-and-mortar pharmacies dropped 10 points in 2024 alone ... Read More: What's Changing For Home Buyers. PBMs can do this because the three largest—CVS Caremark, Express ...

The obvious answer is pay, and there’s some credence to that explanation. Between 2012 and 2022, pay adjusted for inflation ...